Alterations in Circulating Metabolites with Neuroinflammatory Property and Their Impact on Neurological Function in HIV-1–Infected Individuals on Long-Term Suppressive cART
Restricted accessResearch articleFirst published online February, 2021
Alterations in Circulating Metabolites with Neuroinflammatory Property and Their Impact on Neurological Function in HIV-1–Infected Individuals on Long-Term Suppressive cART
HeatonRK, CliffordDB, FranklinDRJr, et al.: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 2010; 75:2087–2096.
2.
Frank deWolf, MohsenGhanbari, SilvanLicher, et al.: Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study. Brain, 2020; 143:1220–1232.
3.
HemalathaBabu, AnoopT. Ambikan, Erin E. Gabriel, et al. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front Immunol, 2019; 10:1965.
4.
HemalathaBabu, MaikeSperk, AnoopT, et al.: Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy. Metabolites, 2019; 9:210.
